+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infection Drug"

Anti-Infectives: Global Strategic Business Report - Product Thumbnail Image

Anti-Infectives: Global Strategic Business Report

  • Report
  • March 2024
  • 116 Pages
  • Global
From
From
H3N2 infection - Pipeline Insight, 2024 - Product Thumbnail Image

H3N2 infection - Pipeline Insight, 2024

  • Drug Pipelines
  • February 2024
  • 80 Pages
  • Global
From
H1N1 infection - Pipeline Insight, 2023 - Product Thumbnail Image

H1N1 infection - Pipeline Insight, 2023

  • Clinical Trials
  • May 2023
  • 80 Pages
  • Global
From
Hepatitis C Virus Infection - Pipeline Insight, 2023 - Product Thumbnail Image

Hepatitis C Virus Infection - Pipeline Insight, 2023

  • Clinical Trials
  • May 2023
  • 80 Pages
  • Global
From
From
From
COVID-19 Current Therapy Global Market Report 2024 - Product Thumbnail Image

COVID-19 Current Therapy Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Antifungals Global Market Report 2024 - Product Thumbnail Image

Antifungals Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Antivirals Global Market Report 2024 - Product Thumbnail Image

Antivirals Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
Loading Indicator

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs. Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more